Neutropenia. Neutropenia
Conditions
Interventions
Intervention 1: First intervention group: Patients will receive daily 5µg/kg of G-CSF (Filgrastim brand) in addition to the antibiotic received in accordance to the protocol. Intervention 2: Second in
Sponsors
Gorgan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 14 Years
Inclusion criteria
Inclusion criteria: patients with cancer associated with neutropenia Parents' informed consent for their child's participation in the study patients with absolute neutrophil count<1500 with one of the following items: Neutropenia lasts for more than 7-10 days Low blood pressure Profound neutropenia Sepsis pneumonia fungal infections
Exclusion criteria
Exclusion criteria: Patients with less than 1500 neutrophils while they have active leukemia or their leukemia is not in the remission phase.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ANC increase rate. Timepoint: Each 48 hours will be done, and when the ANC is over 1500, the medication will be discontinued. Method of measurement: Study of CBC Elements.;Number of hospitalization days. Timepoint: Hospitalize duration. Method of measurement: from patient documents.;Number of days that patient received antibiotics. Timepoint: Hospitalize duration. Method of measurement: from patient documents.;Time taken to stop the fever. Timepoint: Hospitalize duration. Method of measurement: from patient documents. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Sepide Bagheri
Gorgan University of Medical Sciences
Outcome results
None listed